BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9263016)

  • 1. A novel first primary anchor extends the MHC class II I-Ad binding motif to encompass nine amino acids.
    Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
    Int Immunol; 1997 Aug; 9(8):1185-93. PubMed ID: 9263016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1 clones that suppress IgG2ab specifically recognize an allopeptide determinant comprising residues 435-451 of gamma 2ab.
    Bartnes K; Rekdal O; Briand JP; Hannestad K
    Eur J Immunol; 1993 Oct; 23(10):2655-60. PubMed ID: 7691612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retro-inverso analog mimics the cognate peptide epitope of a CD4+ T cell clone.
    Bartnes K; Hannestad K; Guichard G; Briand JP
    Eur J Immunol; 1997 Jun; 27(6):1387-91. PubMed ID: 9209489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
    Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
    Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.
    Bartnes K; Hannestad K
    Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-binding motifs of the mixed haplotype Abetaz/Aalphad major histocompatibility complex class II molecule: a restriction element for auto-reactive T cells in (NZBxNZW)F1 mice.
    Mine M; Koarada S; Sai T; Miyake K; Kimoto M
    Immunology; 1998 Dec; 95(4):577-84. PubMed ID: 9893048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed isotype class II antigen expression. A novel class II molecule is expressed on a murine B cell lymphoma.
    Spencer JS; Kubo RT
    J Exp Med; 1989 Mar; 169(3):625-40. PubMed ID: 2647893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of pigeon cytochrome c-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule.
    Itoh Y; Kajino K; Ogasawara K; Takahashi A; Namba K; Negishi I; Matsuki N; Iwabuchi K; Kakinuma M; Good RA; Onoé K
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12047-52. PubMed ID: 9342360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P9 peptide sidechain specificity of I-Ad.
    Bartnes K; Li X; Briand JP; Travers PJ; Hannestad K
    Immunol Lett; 1999 Dec; 70(3):199-202. PubMed ID: 10656674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of the interaction of apamin with Ia and its recognition by Ad- or Ab-restricted mouse T cells.
    Regnier-Vigouroux A; Ceard B; Van Rietschoten J; Granier C; Pierres M
    J Immunol; 1989 Nov; 143(10):3167-74. PubMed ID: 2478620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I-Ep-bound self-peptides: identification, characterization, and role in alloreactivity.
    Felix NJ; Suri A; Walters JJ; Horvath S; Gross ML; Allen PM
    J Immunol; 2006 Jan; 176(2):1062-71. PubMed ID: 16393994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation.
    Rosloniec EF; Vitez LJ; Buus S; Freed JH
    J Exp Med; 1990 May; 171(5):1419-30. PubMed ID: 2332729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S; Humphreys RE
    Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.
    Stebbins CC; Loss GE; Elias CG; Chervonsky A; Sant AJ
    J Exp Med; 1995 Jan; 181(1):223-34. PubMed ID: 7807005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.